Skip to main content
. 2017 Sep 13;9(3):35. doi: 10.3390/pharmaceutics9030035

Figure 6.

Figure 6

Systemic exposure (AUClast) of Dox after PO administration of DoxQ alone or after cycloheximide IP followed by DoxQ PO in rat serum (n = 4 mean ± SEM). * p < 0.05 Dox after DoxQ versus Dox after cycloheximide + DoxQ.